The development by Dr. W.S. Loewe, German Jewish refugee doctor, of a new drug which provides effective relief and a possible cure for hay fever, was revealed here today. An article in the current Bulletin of the New York Academy of Medicine said that Dr. Loews, who is now teaching at the University of Utah, spent 25 years experimenting and developing anthallan, the new drug.
Anthallan has been used experimentally for two years, and in some cases the patients have had no recurrence of hay fever during that period. In general the drug has been 75 percent effective among the patients who were used in experiments conducted by several doctors from the Vanderbilt Clinic here. The drug, which is taken in six daily pill doses for a period of three weeks, attacks the cause of the ailment rather than the symptom.
Help ensure Jewish news remains accessible to all. Your donation to the Jewish Telegraphic Agency powers the trusted journalism that has connected Jewish communities worldwide for more than 100 years. With your help, JTA can continue to deliver vital news and insights. Donate today.
The Archive of the Jewish Telegraphic Agency includes articles published from 1923 to 2008. Archive stories reflect the journalistic standards and practices of the time they were published.
